Salicylate inhibits lysine acetyltransferases and MUC1 induces epithelial to mesenchymal transition, which could inhibit colorectal cancer progression since overexpressed MUC1 in colorectal cancer cells is associated with worse prognosis [51]. Here, MUC1 is linked to colorectal cancer.